OxStem Cardio, co-founded with Prof. Roger Patient (Professor of Developmental Genetics Weatherall Institute of Molecular Medicine) and Professor Paul Riley (British Heart Foundation Professor of Regenerative Medicine), aims to identify drugs that will restore lost tissue following a heart attack by inducing cardiovascular regeneration, in order to improve cardiac function. This collaborative project will be funded within the University over the next three years following OxStem’s record £16.9M initial fundraise earlier this year.
A fourth subsidiary of OxStem Ltd, an Oxford spin-out co-founded by Professor Steve Davies and Professor Angela Russell has been launched.